BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

848 related articles for article (PubMed ID: 24702900)

  • 1. Interaction between single-dose Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus vaccines on dually infected pigs.
    Park SJ; Seo HW; Park C; Chae C
    Res Vet Sci; 2014 Jun; 96(3):516-22. PubMed ID: 24702900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of combined vaccination against Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus in dually infected pigs.
    Bourry O; Fablet C; Simon G; Marois-Créhan C
    Vet Microbiol; 2015 Nov; 180(3-4):230-6. PubMed ID: 26422712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of porcine circovirus type 2 and Mycoplasma hyopneumoniae vaccines on dually infected pigs.
    Seo HW; Park SJ; Park C; Chae C
    Vaccine; 2014 May; 32(21):2480-6. PubMed ID: 24631087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Mycoplasma hyopneumoniae vaccine on pigs naturally infected with M. hyopneumoniae and porcine reproductive and respiratory syndrome virus.
    Moreau IA; Miller GY; Bahnson PB
    Vaccine; 2004 Jun; 22(17-18):2328-33. PubMed ID: 15149792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of combined porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae vaccination in piglets.
    Drexler CS; Witvliet MH; Raes M; van de Laar M; Eggen AA; Thacker EL
    Vet Rec; 2010 Jan; 166(3):70-4. PubMed ID: 20081177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vaccination on the potentiation of porcine reproductive and respiratory syndrome virus (PRRSV)-induced pneumonia by Mycoplasma hyopneumoniae.
    Thacker EL; Thacker BJ; Young TF; Halbur PG
    Vaccine; 2000 Jan; 18(13):1244-52. PubMed ID: 10649626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy of a trivalent vaccine mixture against a triple challenge with Mycoplasma hyopneumoniae, PCV2, and PRRSV and the efficacy comparison of the respective monovalent vaccines against a single challenge.
    Oh T; Park KH; Yang S; Jeong J; Kang I; Park C; Chae C
    BMC Vet Res; 2019 Oct; 15(1):342. PubMed ID: 31619295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 3 vaccination strategies against porcine reproductive and respiratory syndrome virus,
    Jeong J; Kang I; Kim S; Park KH; Park C; Chae C
    Can J Vet Res; 2018 Jan; 82(1):39-47. PubMed ID: 29382967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 2 commercial single-dose Mycoplasma hyopneumoniae vaccines and porcine reproductive and respiratory syndrome virus (PRRSV) vaccines on pigs dually infected with M. hyopneumoniae and PRRSV.
    Park C; Kang I; Seo HW; Jeong J; Choi K; Chae C
    Can J Vet Res; 2016 Apr; 80(2):112-23. PubMed ID: 27127338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal vaccination strategy against Mycoplasma hyopneumoniae, porcine reproductive and respiratory syndrome virus, and porcine circovirus type 2 in case of early M. hyopneumoniae infection.
    Yang S; Oh T; Mago J; Iwakuma A; Chae C
    Vet Med Sci; 2020 Nov; 6(4):860-874. PubMed ID: 32462794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porcine respiratory disease complex: Interaction of vaccination and porcine circovirus type 2, porcine reproductive and respiratory syndrome virus, and Mycoplasma hyopneumoniae.
    Chae C
    Vet J; 2016 Jun; 212():1-6. PubMed ID: 27256017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased production of proinflammatory cytokines following infection with porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae.
    Thanawongnuwech R; Thacker B; Halbur P; Thacker EL
    Clin Diagn Lab Immunol; 2004 Sep; 11(5):901-8. PubMed ID: 15358650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid-mediated growth hormone-releasing hormone efficacy in reducing disease associated with Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus infection.
    Thacker EL; Holtkamp DJ; Khan AS; Brown PA; Draghia-Akli R
    J Anim Sci; 2006 Mar; 84(3):733-42. PubMed ID: 16478966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
    Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycoplasma hyorhinis is a potential pathogen of porcine respiratory disease complex that aggravates pneumonia caused by porcine reproductive and respiratory syndrome virus.
    Lee JA; Oh YR; Hwang MA; Lee JB; Park SY; Song CS; Choi IS; Lee SW
    Vet Immunol Immunopathol; 2016 Sep; 177():48-51. PubMed ID: 27436444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modified live PRRSV vaccine and the pathogenic parent strain induce regulatory T cells in pigs naturally infected with Mycoplasma hyopneumoniae.
    LeRoith T; Hammond S; Todd SM; Ni Y; Cecere T; Pelzer KD
    Vet Immunol Immunopathol; 2011 Apr; 140(3-4):312-6. PubMed ID: 21272944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of vaccination against porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) in a PCV2-PRRSV challenge model.
    Park C; Oh Y; Seo HW; Han K; Chae C
    Clin Vaccine Immunol; 2013 Mar; 20(3):369-76. PubMed ID: 23302743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses induced in mice immunized with recombinant adenovectors expressing chimeric proteins of various porcine pathogens.
    Roques E; Girard A; Gagnon CA; Archambault D
    Vaccine; 2013 May; 31(24):2698-704. PubMed ID: 23583895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a new bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae (Fostera™ PCV MH) under experimental conditions.
    Park C; Jeong J; Choi K; Chae C
    Vaccine; 2016 Jan; 34(2):270-275. PubMed ID: 26626212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An interferon inducing porcine reproductive and respiratory syndrome virus vaccine candidate elicits protection against challenge with the heterologous virulent type 2 strain VR-2385 in pigs.
    Fontanella E; Ma Z; Zhang Y; de Castro AM; Shen H; Halbur PG; Opriessnig T
    Vaccine; 2017 Jan; 35(1):125-131. PubMed ID: 27876202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.